Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis

19 Aug 2019

Abstract excerpt

OBJECTIVES: To describe the prevalence and clinical associations of autoantibodies to a novel autoantigen, eukaryotic initiation factor 3 (eIF3), detected in idiopathic inflammatory myositis. METHODS: Sera or plasma from 678 PM patients were analysed for autoantigen specificity by radio-labelled protein immunoprecipitation (IPP). Samples immunoprecipitating the same novel autoantigens were further analysed by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Myopathies and Dermatomyositis
Share to Systemic Lupus Erythematosus Research
Share to Systemic Sclerosis and Related Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31728542
DOI: 10.1093/rheumatology/kez406

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositisPMID 31728542Read ↗

Anti-signal recognition particle autoantibody ELISA validation and clinical associationsSemantic proximity Read ↗

Pathogenic autoantibody internalization in myositisSemantic proximity Read ↗

Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis.Semantic proximity Read ↗

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in dermatomyositis patients with anti-TIF1γ autoantibodiesSemantic proximity Read ↗

Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.Semantic proximity Read ↗

A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody TestingSemantic proximity Read ↗

Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.Semantic proximity Read ↗

Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathiesSemantic proximity Read ↗

Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISASemantic proximity Read ↗

Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcomeSemantic proximity Read ↗

Peripheral T-cell lymphoma emerging in a patient with aggressive polymyositis: molecular evidence for neoplastic transformation of an oligoclonal T-cell infiltrate.Semantic proximity Read ↗

Autoantibodies against a 43 KDa Muscle Protein in Inclusion Body MyositisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.